Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rolf Gericke is active.

Publication


Featured researches published by Rolf Gericke.


Pflügers Archiv: European Journal of Physiology | 1989

Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments

J.-E. de Peyer; Ingeborg Lues; Rolf Gericke; G. Häusler

Introduction Recent publication have indicated that some benzopyran derivatives (e.g. cromakalim) are potent relaxants of a number of smooth muscles. Their main pharmacological properties are most probably related to their ability to hyperpolarize the membranes of smooth muscle cells by increasing the conductance to potassium ions (Hamilton et al. 1986). We have therefore explored the possibility that a newly synthetised derivative, EMD 52692 (4-(1,2-dihydro-2-oxo1 -pyridyl)-2,2-dimethyl-2H1-benzo pyran-6-carbonitrile), also induces vascular relaxation by a similar mechanism.


Tetrahedron Letters | 1992

The transformation of a chromene derivative into benzofurans via allene intermediates

Rolf Gericke; Inge Lues

Abstract On LDA-treatment of chromene 1, allenyl phenol 3 is formed which recyclizes in solution. Acetate 4 gives benzofuran derivatives on thermal cyclization.


Journal of Medicinal Chemistry | 1990

Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators

Rolf Bergmann; Rolf Gericke


Journal of Medicinal Chemistry | 2004

Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors

Timo Heinrich; Henning Böttcher; Rolf Gericke; Gerd Bartoszyk; Soheila Anzali; Christoph Seyfried; Hartmut Greiner; Christoph Van Amsterdam


Journal of Medicinal Chemistry | 1997

(2-Methyl-5-(methylsulfonyl)benzoyl)guanidine Na+/H+ antiporter inhibitors.

Manfred Baumgarth; Norbert Beier; Rolf Gericke


Journal of Medicinal Chemistry | 1991

3-methyl-2H-1-benzopyran potassium channel activators

Rolf Gericke; Juergen Harting; Inge Lues; Christine Schittenhelm


Journal of Medicinal Chemistry | 1990

4-Heterocyclyloxy-2H-1-benzopyran potassium channel activators.

Rolf Bergmann; Volker Eiermann; Rolf Gericke


Journal of Medicinal Chemistry | 1998

Bicyclic Acylguanidine Na+/H+ Antiporter Inhibitors

Manfred Baumgarth; Norbert Beier; Rolf Gericke


Archive | 1995

4-amino-1-piperidylbenzoylguanidines

Rolf Gericke; Manfred Baumgarth; Dieter Dorsch; Norbert Beier; Klaus-Otto Dr. Minck; Ingeborg Lues


Archive | 2003

Use of 4 amino-quinazolines as anti cancer agents

Gerhard Barnickel; Hans-Michael Eggenweiler; Volker Eiermann; Rolf Gericke; Wilfried Rautenberg; Christian Sirrenberg; Burkhard Scharm

Collaboration


Dive into the Rolf Gericke's collaboration.

Researchain Logo
Decentralizing Knowledge